Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury-Reference-Cited by-同舟云学术

Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury

Published:2018-08-24 Issue:2 Volume:166 Page:441-450
ISSN:1096-6080
Container-title:Toxicological Sciences
language:en
Short-container-title:

Author:

Obajdin Jana¹²,Cotter Mabel¹³,Snelling Sara¹⁴,Dremier Sarah¹⁵,De Ron Pierrette¹,Fleurance Renaud¹,Valentin Jean-Pierre¹,Nogueira da Costa André⁶,Gryshkova Vitalina¹

Affiliation:

1. Department of Development Science, Investigative Toxicology

2. Centre for Stem Cells & Regenerative Medicine King’s College London, Tower Wing Guy’s Campus Great Maze Pond London SE1 9RT, UK

3. Safety & Environmental Assurance Centre, Unilever U.K., Unilever House, Blackfriars, London EC4Y 0DY, UK

4. Immunology, Abzena, Babraham Research Campus, Cambridge CB22 3AT, UK

5. Ogeda SA, 47 Rue Adrienne Bolland, Gosselies, Belgium 6041, Sarah Dremier

6. Department of Translational Medicine, Experimental Medicine and Diagnostics, UCB Biopharma SPRL, Chemin du Foriest 1, B-1420 Braine L'Alleud, Belgium

Funder

Walloon Region

Publisher

Oxford University Press (OUP)

Subject

Toxicology

Link

http://academic.oup.com/toxsci/article-pdf/166/2/441/26827331/kfy204.pdf

Reference40 articles.

1. Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic acid;Betton;Toxicol. Pathol.,2012

2. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease;Board;Kidney Int. Suppl,2013

3. Next-generation biomarkers for detecting kidney toxicity;Bonventre;Nat. Biotechnol.,2010